2,820
Views
4
CrossRef citations to date
0
Altmetric
Research Papers

From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?

, , ORCID Icon & ORCID Icon
Pages 1704-1714 | Received 17 Apr 2022, Accepted 20 May 2022, Published online: 13 Jun 2022